Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suppression of Myopia Progression with Low-Concentration Atropine (SMLA)
jRCTs051180170Completed
- Sponsor
- Menicon
- Start
- Mar 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of atropine and cyclopentolate in myopia (3 arms), sponsored by Menicon. Primary endpoint: Change in objective spherical equivalent at 24 months. Started Mar 2014; status: completed.
02
Drugs
atropinecyclopentolate
03
Conditions
myopia
Beyond the preview
Go deeper on jRCTs051180170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180170.